Role of KCNJ5 in familial and sporadic primary aldosteronism (Q38066356)

28 August 2017

1 reference

title

Role of KCNJ5 in familial and sporadic primary aldosteronism (English)

1 reference

28 August 2017

3

William E Rainey

1 reference

28 August 2017

Paolo Mulatero

1

1 reference

28 August 2017

Silvia Monticone

series ordinal

2

1 reference

28 August 2017

Franco Veglio

series ordinal

4

1 reference

28 August 2017

Tracy Ann Williams

series ordinal

5

1 reference

28 August 2017

publication date

11 December 2012

1 reference

Nature Reviews Endocrinology

28 August 2017

published in

1 reference

28 August 2017

volume

9

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

104-112

1 reference

Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Cardiovascular outcomes in patients with primary aldosteronism after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Prevalence and characteristics of the metabolic syndrome in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Frequency of familial hyperaldosteronism type 1 in a hypertensive pediatric population: clinical and biochemical presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Generation of a constitutive Na+-dependent inward-rectifier current in rat adult atrial myocytes by overexpression of Kir3.4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Role of G protein-gated inwardly rectifying potassium channels in P2Y12 receptor-mediated platelet functional responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Identification of native atrial G-protein-regulated inwardly rectifying K+ (GIRK4) channel homomultimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Abnormal heart rate regulation in GIRK4 knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Evaluation of the role of I(KACh) in atrial fibrillation using a mouse knockout model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Predisposition to late-onset obesity in GIRK4 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Identification of a Kir3.4 mutation in congenital long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Glomerulosa cell--a unique sensor of extracellular K+ concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

TASK1 and TASK3 potassium channels: determinants of aldosterone secretion and adrenocortical zonation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

The potassium channel, Kir3.4 participates in angiotensin II-stimulated aldosterone production by a human adrenocortical cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Characterization of a novel somatic KCNJ5 mutation delI157 in an aldosterone-producing adenoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

TASK channel deletion in mice causes primary hyperaldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Function and biological roles of the Dickkopf family of Wnt modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Dkk3 is a component of the genetic circuitry regulating aldosterone biosynthesis in the adrenal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Integrating genetics and genomics in primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Mutations of the potassium channel KCNJ5 causing aldosterone-producing adenomas: one or two hits?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Visinin-like proteins (VSNLs): interaction partners and emerging functions in signal transduction of a subfamily of neuronal Ca2+ -sensor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

The orphan nuclear receptor NGFIB regulates transcription of 3beta-hydroxysteroid dehydrogenase. implications for the control of adrenal functional zonation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Regulation of aldosterone synthase by activator transcription factor/cAMP response element-binding protein family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Differential effects of high and low steroidogenic factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Acute and chronic regulation of aldosterone production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Familial or genetic primary aldosteronism and Gordon syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Is familial hyperaldosteronism underdiagnosed in hypertensive children?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2012.230

Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance

31 March 2020

1 reference

12 December 2020

Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism

1 reference

12 December 2020

Control of adrenal cell proliferation by AT1 receptors in response to angiotensin II and low-sodium diet

1 reference

12 December 2020

Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol

1 reference

12 December 2020

Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone

1 reference

12 December 2020

The role of TASK1 in aldosterone production and its expression in normal adrenal and aldosterone-producing adenomas

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2012.230

1 reference

Dimensions Publication ID

28 August 2017

1035820533

0 references

Fatcat ID

release_6ure2ofjcje6vcqb5ym4oxqdsu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6ure2ofjcje6vcqb5ym4oxqdsu

24 November 2022

mapped directly with Wikidata item

1 reference